Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Nilesh Ranjan"'
Autor:
Varsha Hande, Nilesh Ranjan, Supriya Chopra, Shwetabh Sinha, Prachi Mittal, Ankita Gupta, Amita Maheshwari, Sudeep Gupta
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThe PARCER trial provided level I evidence for image-guided intensity-modulated radiation therapy (IG-IMRT) in patients with cervical cancer. Further information regarding long-term financial impact is imperative for adoption into the National
Externí odkaz:
https://doaj.org/article/9256c8d9994a40348f05dd9fa99c0244
Autor:
Nilesh Ranjan, Supriya Chopra, Akshay Mangaj, Pallavi Rane, Mayuri Charnalia, Sadhana Kannan, Tapas Dora, Reena Engineer, Umesh Mahantshetty, Lavanya Gurram, Prachi Mittal, Jaya Ghosh, Amita Maheshwari, TS Shylasree, Sudeep Gupta, SK Shrivastava
Publikováno v:
EClinicalMedicine, Vol 47, Iss , Pp 101390- (2022)
Summary: Background: Adverse event reporting in oncology trials lacks temporal description. We propose a toxicity summarizing method that incorporates time. Methods: Patients recruited in a phase III trial (NCT01279135) that compared three-dimensiona
Externí odkaz:
https://doaj.org/article/5c2099a26379442e9b62e51265eb5f35
Autor:
Supriya Chopra, Jagadish Shejul, Nilesh Ranjan, Umesh Mahantshetty, Shaesta Mehta, Prachi Patil, Reena Engineer, Lavanya Gurram, Reena Phurailatpam, Jamema Swamidas, Sudeep Gupta, Shyam Shrivastava
Publikováno v:
The Indian journal of medical research. 154(2)
There is limited information available on the temporal course of late stage radiotherapy adverse effects. The present study reports on the temporal course of late toxicities after chemoradiation and brachytherapy.: Women with cervical cancer who pres
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 32(3)
Early stage cervical cancer, stages IB1–2 and IIA1, can be treated with (chemo)radiation and brachytherapy or radical hysterectomy with or without further adjuvant (chemo)radiation. In a carefully selected cohort for surgery, traditionally a small
Autor:
Supriya, Chopra1 (AUTHOR) schopra@actrec.gov.in, Nilesh, Ranjan2 (AUTHOR), Mayuri, Charnalia1 (AUTHOR), Sadhana, Kannan3 (AUTHOR), Reena, Engineer2 (AUTHOR), Tapas, Dora4 (AUTHOR), Lavanya, Gurram2 (AUTHOR), Prachi, Mittal2 (AUTHOR), Amita, Maheshwari5 (AUTHOR), Shylasree, T.S.5 (AUTHOR), Shyam, Shrivastava2 (AUTHOR), Sudeep, Gupta6 (AUTHOR)
Publikováno v:
Radiotherapy & Oncology. Dec2022, Vol. 177, p16-20. 5p.
Publikováno v:
European Journal of Biochemistry. 3/1/97, Vol. 244 Issue 2, p407-413. 7p.
Autor:
Eric M. Jones, Nilesh Ranjan Maiti, Krystyna Surewicz, Witold K. Surewicz, Bishwajit Kundu, David L. Vanik
Publikováno v:
Proceedings of the National Academy of Sciences. 100:12069-12074
One of the most intriguing disease-related mutations in human prion protein (PrP) is the Tyr to Stop codon substitution at position 145. This mutation results in a Gerstmann–Straussler–Scheinker-like disease with extensive PrP amyloid deposits in
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1343:251-262
UDP-galactose 4-epimerase from yeast Kluyveromyces fragilis is a dimeric molecule of 75 kDa per subunit with one molecule of cofactor NAD per dimer. It undergoes unfolding and complete dissociation in presence of 8 M urea at pH 7.0 by 10 min. It can
Publikováno v:
European Journal of Biochemistry. 244:407-413
UDP-galactose 4-epimerase from Escherichia coli is a homodimer of 39-kDa subunits having 1 or 2 molecules of NAD bound non-covalently/dimer. The enzyme can be dissociated and denatured by 8 M urea at pH 7.0 to a state having only 15% of residual seco
Publikováno v:
The Journal of biological chemistry. 276(4)
It is believed that the critical step in the pathogenesis of transmissible spongiform encephalopathies is a transition of prion protein (PrP) from an alpha-helical conformation, PrP(C), to a beta-sheet-rich form, PrP(Sc). Native prion protein contain